HGF and ischemic disease: Our results are supported by the studies by Hayashi and colleagues [53] who demonstrated that hypoxic treatment of vascular cells downregulated HGF production due to decreased cAMP, consistent with their potential role in the pathophysiology of ischemic diseases.